NCT00168402已完成3 期
A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Allergan
- 入组人数
- 193
- 主要终点
- Subject's assessment of the severity of hyperhidrosis
研究概览
简要总结
This is a three-year study in subjects with axillary hyperhidrosis involving injection of Botulinum Toxin Type A into the axilla to reduce sweating.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Marked axillary hyperhidrosis
排除标准
- •Previous use of botulinum toxin for hyperhidrosis
结局指标
主要结局
Subject's assessment of the severity of hyperhidrosis
次要结局
- Measurement of axillary sweat production
研究者
相似试验
已完成
4 期
A Study Using Botulinum Toxin Type A in Patients With Axillary HyperhidrosisHyperhidrosisNCT00168480Allergan424
已完成
4 期
A Study Using Botulinum Toxin Type A in Adolescents With Axillary HyperhidrosisHyperhidrosisNCT00168415Allergan144
撤回
4 期
Botulinum Toxin-A for Hidradenitis SuppurativaHidradenitis Suppurativa \(HS\)Hidradenitis Suppurativa, Acne InversaHidradenitis SuppurativaNCT06237465Yale University30
已完成
2 期
Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary HyperhidrosisHyperhidrosisNCT02565732Revance Therapeutics, Inc.67
已完成
2 期
A Research Study for Patients With Overactive BladderUrinary IncontinenceOveractive BladderNCT00168454Allergan313